Bank of Montreal
CYTK icon

Bank of Montreal’s Cytokinetics CYTK Stock Holding History

Bank of Montreal’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-104,000
Closed -$497K – 4086
2014
Q2 		$497K Buy
+104,000
New +$635K ﹤0.01% 2091

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of Montreal's CYTK Position: Q2 2026 in Review

Bank of Montreal increased its Cytokinetics (CYTK) stake by 1,855% in Q2 2026, buying an estimated $19.5M and bringing the position to 285,688 shares worth $24.3M. The position accounts for 0.01% of the portfolio, ranked #839.

Bank of Montreal first reported a position in CYTK in Q3 2013 and has held it in 46 quarters since. 286 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Bank of Montreal held 285,688 shares of Cytokinetics worth $24.3M as of Q2 2026.
  • Bank of Montreal bought 271,076 Cytokinetics shares in Q2 2026, an estimated $19.5M.
  • Cytokinetics made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #839 holding.
  • Bank of Montreal first reported a position in Cytokinetics in Q3 2013 and has held it in 46 quarters since.
  • 286 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.